World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
18152
World Ranking
8559
National Ranking
575

Overview

Shigeo Mori is affiliated with the University of Tokyo in Japan. Their academic profile does not list recent papers, co-authors, or specific publication venues, which suggests a limited publicly available record of research outputs in standard bibliographic sources.

There is no available information regarding the main fields and subfields of study associated with Shigeo Mori, nor are there details about principal research topics or thematic areas they have investigated. Similarly, no data about book publications or awards has been provided.

The absence of detailed publication data makes it challenging to outline specific research contributions or collaborations. Despite this, the institutional association with a major academic university indicates a professional engagement in research activities within an academic context.

Given the limited data, it appears the publicly accessible academic footprint of Shigeo Mori is minimal or not documented in the sources referenced.

Best Publications

  • Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology.

    Elaine S. Jaffe;John K.C. Chan;Ih-Jen Su;Glauco Frizzera

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

    Susumu Nakae;Shinobu Saijo;Reiko Horai;Katsuko Sudo

  • Frequent inactivation of A20 in B-cell lymphomas

    Motohiro Kato;Masashi Sanada;Itaru Kato;Yasuharu Sato

  • Tissue Distribution of P-Glycoprotein Encoded by a Multidrug-resistant Gene as Revealed by a Monoclonal Antibody, MRK 16

    Isamu Sugawara;Iyo Kataoka;Yasuyuki Morishita;Hirofumi Hamada

  • Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice

    Hirofumi Nishizumi;Ichiro Taniuchi;Yuji Yamanashi;Daisuke Kitamura

  • Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK : a distinct clinicopathologic entity

    Shiota M;Nakamura S;Ichinohasama R;Abe M

  • HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.

    Manabu Mochizuki;Toshiki Watanabe;Kazunari Yamaguchi;Kiyoshi Takatsuki

  • Hyperphosphorylation of a Novel 80 kDa Protein-Tyrosine Kinase Similar to Ltk in a Human Ki-1 Lymphoma Cell Line, AMS3

    Shiota M;Fujimoto J;Semba T;Satoh H

  • Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.

    Harutaka Katano;Yuko Sato;Takeshi Kurata;Shigeo Mori

  • BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.

    Toshiko Onizuka;Masatsugu Moriyama;Tadanori Yamochi;Toshihiko Kuroda

  • Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.

    Ryouichi Horie;Takuro Watanabe;Yasuyuki Morishita;Kinji Ito

  • Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type.

    Taizan Suchi;Kazuo Tajima;Koji Nanba;Haruki Wakasa

  • Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

    Ritsuro Suzuki;Yoshitoyo Kagami;Kengo Takeuchi;Masahiro Kami

  • Uveitis associated with human T-cell lymphotropic virus type I.

    Manabu Mochizuki;Toshiki Watanabe;Kazunari Yamaguchi;Koichi Yoshimura

  • Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.

    Mami Shiota;Jiro Fujimoto;Masato Takenaga;Hitoshi Satoh

  • Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.

    M Baba;E De Clercq;H Tanaka;M Ubasawa

  • Anaplastic large cell lymphoma : a distinct molecular pathologic entity : a reappraisal with special reference to p80(NPM/ALK) expression

    Shigeo Nakamura;Mami Shiota;Atsuko Nakagawa;Yasushi Yatabe

  • Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

    Naoko Asano;Naoko Asano;Kazuhito Yamamoto;Jun Ichi Tamaru;Takashi Oyama

  • Expression of Epidermal Growth Factor Receptors on Normal Human Gastric Epithelia and Gastric Carcinomas

    Keisuke Sakai;Shigeo Mori;Tomoyuki Kawamoto;Shigehiko Taniguchi

Frequent Co-Authors

Isamu Sugawara
Isamu Sugawara Saitama Medical University
Harutaka Katano
Harutaka Katano National Institutes of Health
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo
Tadashi Yamamoto
Tadashi Yamamoto Okinawa Institute of Science and Technology
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Toshiki Watanabe
Toshiki Watanabe University of Tokyo
Hirofumi Hamada
Hirofumi Hamada Sapporo Medical University
Takashi Tsuruo
Takashi Tsuruo Japanese Foundation For Cancer Research
Yasuo Ohashi
Yasuo Ohashi Chuo University
Kumao Toyoshima
Kumao Toyoshima Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Shigeo Mori

Trending Scientists

Recently Published Articles